Ceritinib/crizotinibDevelopment of resistance: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1662卷 / 1期

关键词：

D O I：

10.1007/s40278-017-33722-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：92 / 92

相关论文

共 50 条

[31] Ceritinib/crizotinibAcquired resistance to crizotinib and ceritinib by an L1152R mutation: case report
Reactions Weekly, 2016, 1617 (1) : 57 - 57
[32] CrizotinibDevelopment of resistance in non-small cell lung cancer: case report
Reactions Weekly, 2017, 1633 (1) : 231 - 231
[33] Alectinib/ceritinib/crizotinibDrug resistance, thrombocytopenia and neutropenia: case report
Reactions Weekly, 2018, 1730 (1) : 18 - 18
[34] CrizotinibDevelopment of resistance in non-small cell lung cancer: case report
Reactions Weekly, 2019, 1754 (1) : 120 - 120
[35] Catequentinib/ceritinib/crizotinibDrug resistance and lack of efficacy : case report
Reactions Weekly, 2023, 1938 (1) : 378 - 378
[36] Alectinib/ceritinib/lorlatinibDevelopment of resistance in SCLC and SCLC transformation: case report
Reactions Weekly, 2017, 1648 (1) : 21 - 21
[37] CrizotinibDevelopment of drug resistance in Anaplastic lymphoma kinase (ALK) fusion adenocarcinoma: case report
Reactions Weekly, 2017, 1668 (1) : 131 - 131
[38] CrizotinibDevelopment of drug resistance in non-small cell lung cancer: case report
Reactions Weekly, 2018, 1733 (1) : 121 - 121
[39] Ceritinib/crizotinibHepatotoxicity: case report
Reactions Weekly, 2018, 1698 (1) : 99 - 99
[40] Ceritinib/crizotinibDiarrhoea: case report
Reactions Weekly, 2017, 1671 (1) : 113 - 113

← 1 2 3 4 5 →